Поиск | All Crowdz

Rutujabg Bhosale добавлена новая статья Networking
2026-03-13 11:45:37 -

Ultomiris Drug Market Trends and Growth Opportunities
Ultomiris Drug Market Overview The Global Ultomiris Drug Market is witnessing remarkable growth and innovation, fueled by increasing adoption of advanced complement inhibitors for rare diseases. According to recent market projections, the global Ultomiris drug market size is expected to rise from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, exhibiting an...

0 Комментарии 0 Поделились 360 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rutujabg Bhosale добавлена новая статья Networking
2026-03-25 11:39:06 -

Ultomiris Drug Market: Growth, Trends, and Global Forecast
Market Overview The global Ultomiris drug market is experiencing strong growth, driven by increasing adoption of advanced biologic therapies for rare diseases. The market is projected to grow from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, registering a CAGR of 14.4%. Ultomiris (ravulizumab), developed by Alexion Pharmaceuticals, is a long-acting C5 complement...

0 Комментарии 0 Поделились 243 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rutujabg Bhosale добавлена новая статья Другое
2026-04-30 05:18:30 -

Ultomiris Market Trends, Growth Drivers, and Future Outlook (2026–2033)
Ultomiris Drug (ravulizumab) Market is a long-acting monoclonal antibody developed to treat rare complement-mediated disorders. As a C5 complement inhibitor, it plays a critical role in managing diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder...

0 Комментарии 0 Поделились 32 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!